Lead Anti-Obesity Compounds from Nature
Vinesh Dahiya1, Neeru Vasudeva1, Sunil Sharma1
1Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India.
Summary
Natural compounds offer a promising approach to combat obesity, a global health challenge. Dietary intake of these active agents can help reduce fat accumulation and adipogenesis in individuals with obesity.
Area of Science:
- Pharmacognosy and Natural Product Chemistry
- Metabolic Health and Obesity Research
Background:
- Obesity is a global health crisis, significantly increasing the risk of metabolic syndrome, including diabetes, cardiovascular disease, hypertension, and cancer.
- Traditional methods like diet and exercise are often insufficient for effective obesity management due to implementation challenges.
Purpose of the Study:
- To identify and review active constituents from natural sources with anti-obesity properties.
- To address the urgent need for effective obesity prevention and control strategies in light of rising global prevalence.
Main Methods:
- Comprehensive literature search of PubMed, Scopus, and other online databases (1975-2019).
- Inclusion of own research, analysis of popular natural products, and review of pharmacognostic and biological studies.
- Investigation into the mechanisms of action of identified natural anti-obesity agents.
Main Results:
- Identification of various natural compounds with demonstrated anti-obesity effects.
- Analysis of pharmacognostic and biological data supporting the efficacy of these natural products.
- Elucidation of the mechanisms by which these compounds suppress lipid accumulation and adipogenesis.
Conclusions:
- Dietary incorporation of natural compounds with anti-obesity activity presents a viable strategy for managing obesity.
- These natural agents show potential in suppressing lipid accumulation and adipogenesis, offering a promising therapeutic avenue.
Keywords:
Obesityanti-lipolytic compoundsanti-obesity compoundsmarine
sourcesnatural productsphytochemicalsplantsMore Related Videos
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
115
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
115
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
180
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
180
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Cancer Prevention
7.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.5K
Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Glucagon-like Receptor Agonists
744
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
744


